Year: 2019

CICERO, Ill., Dec. 09, 2019 (GLOBE NEWSWIRE) — Broadwind Energy, Inc. (NASDAQ: BWEN), a leading precision manufacturer of structures, equipment and components for clean tech and other specialized applications, today announced that its Board of Directors has named Eric Blashford as the Company’s incoming CEO and President, following the retirement of Stephanie Kushner.  The leadership transition is effective March 1, 2020, at which time Mr. Blashford will also be named to the Company’s Board of Directors.  Ms. Kushner will continue to serve as a member of the Board of Directors following her retirement from the Company.“During her tenure as CEO, Stephanie was instrumental in driving transformational strategic initiatives that improved our competitive positioning, diversified the customer base and enhanced the reliability of our manufacturing...

Vancouver, Dec. 09, 2019 (GLOBE NEWSWIRE) — NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) (“NanoSphere” or “the Company”) wishes to provide an update regarding its operations in the United States, along with its California partner, Vertical Companies Inc.We are pleased to announce that Vertical will be completing its first test batch of Evolve Formulas products in the upcoming week. This will be followed by the production of commercial batches of the proprietary, nanoparticle topical cannabis using NanoSphere’s patented technology, for launch to the California market in January, 2020. Per NanoSphere Health Sciences Chief Executive Officer, Dr. Mark Percival: “Entry into California, as the largest legal cannabis market in North America, in partnership with a company as professional and accomplished as Vertical, is a remarkable...

Culver City, CA, Dec. 09, 2019 (GLOBE NEWSWIRE) — eWellness Healthcare Corporation – (EWLL) – a provider of the state of the art PHZIO platform for the physical therapy (“PT”) and telehealth markets, announced today that for any non-affiliated holders of its common stock on Monday, December 9, 2019, the Company will issue to those holders a 20% dividend in the form of the issuance of one new share for each five shares of common stock owned by the non-affiliated shareholders. The Company’s officers, directors and control shareholders will not be issued any of the shares of common stock in the stock dividend. (Specific details will be provided in a to-be-released 8-K filing).Darwin Fogt, MPT CEO of EWLL, stated “Given the dilution that our common shareholders have experienced over the recent months, the Company believes that this...

Joint Venture Expected to Provide Significant Revenue Opportunities & Aligns with Company’s Humanitarian EffortsLAS VEGAS, NV, Dec. 09, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – One World Pharma Inc. (OTCQB: OWPC), “OWP,” a fully licensed pure-play cannabis and hemp ingredient producer in Colombia, announced today that it has partnered with Colombia’s FEDECORE to provide seed-to-sale assistance to qualified local populations in Colombia. FEDECORE is the ‘Colombian Federation of Regional Advisors,’ which defends human rights, promoting inclusive policies, programs, and projects. It is tasked with developing social projects in post-conflict, underdeveloped and struggling municipalities of Colombia to improve the quality of living of the citizens in those regions. Under the joint venture, OWP owns 51% of the shares of Colcannapy...

FAIRFAX, Va., Dec. 09, 2019 (GLOBE NEWSWIRE) — WidePoint Corporation (NYSE American: WYY), the leading provider of Trusted Mobility Management (TM2) specializing in Telecommunications Lifecycle Management, Identity Management and Digital Billing & Analytics solutions, has raised its revenue and adjusted EBITDA guidance for the full year ending December 31, 2019.Subsequent to WidePoint’s third quarter 2019 earnings call held on November 14, 2019, the federal government definitized its budget for the end of 2019. As a result of additional insights gained from the updated budget, WidePoint now anticipates revenues for its full year 2019 to be $95M (previously a range of $90.0 million to $93.0 million) and adjusted EBTIDA to be $3.5M (previously a range of 2.75 million to $3.5 million). The company’s new guidance represents an...

FDA removes clinical hold; Company may proceed with VIITAL™ studyCompany expects to initiate study in the first quarter of 2020Primary endpoint confirmed as proportion of wounds with greater than 50% healing at 3 months vs control woundsMajority of potential subjects have been pre-screened for the studyNEW YORK and CLEVELAND, Dec. 09, 2019 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that the U.S. Food and Drug Administration (FDA) has removed its clinical hold and provided clearance to proceed with the VIITAL™ study, the Company’s pivotal Phase 3 clinical trial evaluating EB-101 for the treatment of recessive dystrophic epidermolysis bullosa (RDEB). The FDA removed the clinical hold following the Company’s submission of additional data points on...

MORRISVILLE, N.C., Dec. 09, 2019 (GLOBE NEWSWIRE) — The Syneos Health® Insights Hub, a dynamic destination for what’s next thinking and future-focused insights, today released 2020 Health Trends: Changing Lives and Life Sciences. This annual trends report outlines critical shifts and the underlying dynamics that will shape biopharmaceutical decision making in 2020. Compiled from hundreds of global trend watchers working on the frontlines of healthcare, the report provides tangible ways for biopharmaceutical companies to navigate what’s ahead to realize the full potential of innovation.“As we enter the next decade, the state of biopharmaceutical change continues to accelerate – from scientific advances redefining what’s possible to new technologies that are changing how we generate and act on data to improve health,” said Alistair...

TORONTO, Dec. 09, 2019 (GLOBE NEWSWIRE) — MacDonald Mines Exploration Ltd. (TSX-V: BMK) (“MacDonald Mines”, “MacDonald” or the “Company”) announces results from four holes of its now completed Fall 2019 drilling program at the Company’s SPJ Property, 40 kilometres east of Sudbury, Ontario. Results are highlighted by hole SM-19-022 with the discovery of a significant zone of near-surface gold mineralization north of the Scadding East-West (“E-W”) Pit – 7.99 g/t gold over 26.2 metres including 10.98 g/t over 4.98 metres and 11.54 g/t over 13.24 metres was intersected from 16 to 42 metres depth. Twenty-five (25) holes have been completed with 9 holes reported to date. The remaining 16 holes are being processed and assay results will be announced as they are received.Table 1. Assay highlights from reported holes* Assays results...

HOPSCOTCH GROUPEInformation mensuelle relative au nombre total des droits de vote et d’actions composant le capital socialArticle 223-16 du règlement Général de l’Autorité des Marchés Financiers*Total réel = nombre total de droits de vote attachés au nombre total d’actions – actions privées de droit de vote (auto détention,…).Pièce jointedroitsdevote 30 nov 2019